VIA
AUPH icon

Virtus Investment Advisers’s Aurinia Pharmaceuticals AUPH Stock Holding History

Virtus Investment Advisers’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$789K Buy
53,267
+10,150
+24% +$148K 0.22% 162
2025
Q4 		$688K Sell
43,117
-10,880
-20% -$154K 0.19% 174
2025
Q3 		$597K Hold
53,997
– – 0.17% 189
2025
Q2 		$457K Buy
53,997
+16,946
+46% +$136K 0.15% 193
2025
Q1 		$298K Sell
37,051
-45,777
-55% -$371K 0.08% 242
2024
Q4 		$744K Hold
82,828
– – 0.58% 40
2024
Q3 		$607K Hold
82,828
– – 0.48% 55
2024
Q2 		$473K Buy
+82,828
New +$436K 0.4% 80

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return